Neural activities of IL-6-type cytokines often depend on soluble cytokine receptors

European Journal of Neuroscience

Volumn 11, Issue 9, 1999, Pages 2995-3004

  März, Pia ^a   Otten, Uwe ^b   Rose John, Stefan ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Cytokines; Cytoplasmic signalling; Interleukin 6; Neuronal differentiation; Soluble receptors; Transsignalling

Indexed keywords

CILIARY NEUROTROPHIC FACTOR; CYTOKINE RECEPTOR; INTERLEUKIN 11; INTERLEUKIN 6; MEMBRANE RECEPTOR; RECEPTOR SUBUNIT;

CELL SURVIVAL; CELL TYPE; LIGAND BINDING; NERVE CELL DIFFERENTIATION; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 0032826994     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9568.1999.00755.x     Document Type: Review

References (106)

1. ACTS (1995). The pharmacokinetics of subcutaneously administered recombinant human ciliary neurotrophic factor (rHCNTF) in patients with amyotrophic lateral sclerosis: relation to parameters of the acute-phase response. The ALS CNTF Treatment Study (ACTS) Phase I-II Study Group. Clin. Neuropharmacol., 18, 500-514.
2. Akira, S., Taga, T. & Kishimoto, T. (1993). Interleukin-6 in biology and medicine. Adv. Immunol., 54, 1-78.
3. Bauer, J., Strauss, S., Schreiter Gasser, U., Ganter, U., Schlegel, P., Witt, I., Yolk, B. & Berger, M. (1991). Interleukin-6 and alpha-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices. FEBS Lett., 285, 111-114.
4. Baumann, H., Wang, Y., Morella, K.K., Lai, C.F., Dams, H., Hilton, D.J., Hawley, R.G. & Mackiewicz, A. (1996). Complex of the soluble IL-11 receptor and IL-11 acts as IL-6-type cytokine in hepatic and nonhepatic cells. J. Immunol., 157, 284-290.
5. Bazan, J.F. (1990a). Haemopoietic receptors and helical cytokines. Immunol. Today, 11, 350-354.
6. Bazan, J.F. (1990b). Structural design and molecular evolution of a cytokine receptor superfamily. Proc. Natl Acad. Sci. USA, 87, 6934-6938.
7. Bazan, J.F. (1991). Neuropoietic cytokines in the hematopoietic fold. Neuron, 7, 197-208.
8. Betz, U.A.K., Bloch, W., van den Broek, M., Yoshida, K., Taga, T., Kishimoto, T., Addicks, K., Rajewsky, K. & Müller, W. (1998). Postnatally induced inactivation of gp130 in mice results in neurological, cardiac, hematopoietic, immunological, hepatic, and pulmonary defects. J. Exp. Med., 188, 1955-1965.
9. Blum-Degen, D., Muller, T., Kuhn, W., Gerlach, M., Przuntek, H. & Riederer, P. (1995). Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients. Neurosci. Lett., 202, 17-20.
10. Bolin, L.M., Verity, A.N., Silver, J.E., Shooter, E.M. & Abrams, J.S. (1995). Interleukin-6 production by Schwann cells and induction in sciatic nerve injury. J. Neurochem., 64, 850-858.
11. Brugg, B., Dubreuil, Y.L., Huber, G., Wollman, E.E., Delhaye Bouchaud, N. & Mariani, J. (1995). Inflammatory processes induce beta-amyloid precursor protein changes in mouse brain. Proc. Natl Acad. Sci. USA, 92, 3032-3035.
12. Campbell, I.L., Abraham, C.R., Masliah, E., Kemper, P., Inglis, J.D., Oldstone, M.B. & Mucke, L. (1993). Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc. Natl Acad. Sci. USA, 90, 10061-10065.
13. Davis, S., Aldrich, T.H., Ip, N.Y., Stahl, N., Scherer, S., Farruggella, T., DiStefano, P.S., Curtis, R., Panayotatos, N., Gascan, H., Chevalier, S. & Yancopulos, G.D. (1993). Released form of CNTF receptor alpha component as a soluble mediator of CNTF responses. Science, 259, 1736-1739.
14. DeChiara, T.M., Vejsada, R., Poueymirou, W.T., Acheson, A., Suri, C., Conover, J.C., Friedman, B., McClain, J., Pan, L., Stahl, N. &. et al. (1995). Mice lacking the CNTF receptor, unlike mice lacking CNTF, exhibit profound motor neuron deficits at birth. Cell, 83, 313-322.
15. Escary, J.L., Perreau, J., Dumenil, D., Ezine, S. & Brulet, P. (1993). Leukaemia inhibitory factor is necessary for maintenance of haematopoietic stem cells and thymocyte stimulation. Nature, 363, 361-364.
16. Fann, M.J. & Patterson, P.H. (1994). Neuropoietic cytokines and activin A differentially regulate the phenotype of cultured sympathetic neurons. Proc. Natl Acad. Sci. USA, 91, 43-47.
17. Fischer, M., Goldschmitt, J., Peschel, C., Kallen, K.J., Brakenhoff, J.P.J., Wollmer, A., Grötzinger, J. & Rose-John, S. (1997). A designer cytokine with high activity on human hematopoietic progenitor cells. Nature Biotech., 15, 142-145.
18. Francis, N.J., Asmus, S.E. & Landis, S.C. (1997). CNTF and LIF are not required for the target-directed acquisition of cholinergic and peptidergic properties by sympathetic neurons in vivo. Dev. Biol., 182, 76-87.
19. Frieling, J.T., Sauerwein, R.W., Wijdenes, J., Hendriks, T. & van der Linden, C.J. (1994). Soluble interleukin 6 receptor in biological fluids from human origin. Cytokine, 6, 376-381.
20. Gadient, R.A. & Otten, U. (1993). Differential expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) mRNAs in rat hypothalamus. Neurosci. Lett., 153, 13-16.
21. Gadient, R.A. & Otten, U. (1994). Expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) mRNAs in rat brain during postnatal development. Brain Res., 637, 10-14.
22. Gadient, R.A. & Otten, U. (1996). Postnatal expression of interleukin-6 (IL-6) and IL-6 receptor (IL-6R) mRNAs in rat sympathetic and sensory ganglia. Brain Res., 724, 41-46.
23. Gearing, D.P., Gough, N.M., King, J.A., Hilton, D.J., Nicola, N.A., Simpson, R.J., Nice, E.C., Kelso, A. & Metcalf, D. (1987). Molecular cloning and expression of cDNA encoding a murine myeloid leukaemia inhibitory factor (LIF). EMBO J., 6, 3995-4002.
24. Geissen, M., Heller, S., Pennica, D., Ernsberger, U. & Rohrer, H. (1998). The specification of sympathetic neurotransmitter phenotype depends on gp130 cytokine receptor signaling. Development, 125, 4791-4801.
25. Greene, L.A., Aletta, J.M., Rukenstein, A. & Green, S.H. (1987). PC12 pheochromocytoma cells: culture, nerve growth factor treatment, and experimental exploitation. Meth. Enzymol., 147, 207-216.
26. Greene, L.A. & Tischler, A.S. (1976). Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl Acad. Sci. USA, 73, 2424-2428.
27. Grötzinger, J., Kurapkat, G., Wollmer, A., Kalai, M. & Rose-John, S. (1997). The family of the IL-6-type cytokines: specificity and promiscuity of the receptor complexes. Proteins Structure, Function Genet., 27, 96-109.
28. Gruol, D.L. & Nelson, T.E. (1997). Physiological and pathological roles of interleukin-6 in the central nervous system. Mol. Neurobiol., 15, 307-339.
29. Habecker, B.A., Symes, A.J., Stahl, N., Francis, N.J., Economides, A., Fink, J.S., Yancopoulos, G.D. & Landis, S.C. (1997). A sweat gland-derived differentiation activity acts through known cytokine signaling pathways. J. Biol. Chem., 272, 30421-30428.
30. Hampel, H., Schoen, D., Schwarz, M.J., Kotter, H.U., Schneider, C., Sunderland, T., Dukoff, R., Levy, J., Padberg, F., Stubner, S., Buch, K., Muller, N. & Moller, H.J. (1998). Interleukin-6 is not altered in cerebrospinal fluid of first-degree relatives and patients with Alzheimer's disease. Neurosci. Lett., 228, 143-146.
31. Hibi, M., Murakami, M., Saito, M., Hirano, T., Taga, T. & Kishimoto, T. (1990). Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell, 63, 1149-1157.
32. Hirano, T., Nakajima, K. & Hibi, M. (1997). Signaling mechanisms through gp130: a model of the cytokine system. Cytokine Growth Factor Rev., 4, 241-252.
33. Hirota, H., Kiyama, H., Kishimoto, T. & Taga, T. (1996). Accelerated Nerve Regeneration in Mice by upregulated expression of interleukin (IL) 6 and IL-6 receptor after trauma. J. Exp. Med., 183, 2627-2634.
34. Hopkins, S.J. & Rothwell, N.J. (1995). Cytokines and the nervous system I: expression and recognition. Trends Neurosci., 18, 83-88.
35. Hüll, M., Strauss, S., Berger, M., Volk, B. & Bauer, J. (1996). The participation of interleukin-6, a stress-inducible cytokine, in the pathogenesis of Alzheimer's diseas patients. Behav. Brain Res., 78, 37-41.
36. Hüll, M., Strauss, S., Volk, B., Berger, M. & Bauer, J. (1995). Interleukin-6 is present at early stages of plaques formation and is restricted to the brains of Alzheimer's disease patients. Acta Neuropathol., 89, 544-551.
37. Ikeda, K., Iwasaki, Y., Shiojima, T. & Kinoshita, M. (1996a). Neuroprotective effect of various cytokines on developing spinal motoneurons following axotomy. J. Neurol. Sci., 135, 109-113.
38. Ikeda, K., Kinoshita, M., Tagaya, N., Shiojima, T., Taga, T., Yasukawa, K., Suzuki, H. & Okano, A. (1996b). Coadministration of interleukin-6 (IL-6) and soluble IL-6 receptor delays progression of wobbler mouse motor neuron disease. Brain Res., 726, 91-97.
39. Ito, Y., Yamamoto, M., Li, M., Doyu, M., Tanaka, F., Mutch, T., Mitsuma, T. & Sobue, G. (1998). Differential temporal expression of mRNAs for ciliary neurotrophic factor (CNTF), leukemia inhibitory factor (LIF), interleukin-6 (IL-6), and their receptors (CNTFR alpha, LIFR beta, IL-6R alpha and gp130) in injured peripheral nerves. Brain Res., 793, 321-327.
40. Kallen, K.-J., Meyer zum Büschenfelde, K.H. & Rose-John, S. (1997). The therapeutic potential of interleukin-6 hyperagonists and antagonists. Exp. Opin. Invest. Drugs, 6, 237-266.
41. Kalman, J., Juhasz, A., Laird, G., Dickens, P., Jardanhazy, T., Rimanoczy, A., Boncz, I., Parry-Jones, W.L.I. & Janka, Z. (1997). Serum interleukin-6 levels correlate with the severity of dementia in Down syndrome and in Alzheimer disease. Acta Neurol. Scand., 96, 236-240.
42. Kiefer, R., Lindholm, D. & Kreutzberg, G.W. (1993). Interleukin-6 and transforming growth factor-beta 1 mRNAs are induced in rat facial nucleus following motoneuron axotomy. Eur. J. Neurosci, 5, 775-781.
43. Klein, M.A., Moller, J.C., Jones, L.L., Bluethmann, H., Kreutzberg, G.W. & Raivich, G. (1997). Impaired neuroglial activation in interleukin-6 deficient mice. Glia, 19, 227-233.
44. Kopf, M., Baumann, H., Freer, G., Freudenberg, M., Lamers, M., Kishimoto, T., Zinkernagel, R., Bluethmann, H. & Kohler, G. (1994). Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature, 368, 339-342.
45. Landis, S.C. (1994). Development of sympathetic neurons: neurotransmitter plasticity and differentiation factors. Prog. Brain Res., 100, 19-23.
46. Layton, M.J., Cross, B.A., Metcalf, D., Ward, L.D., Simpson, R.J. & Nicola, N.A. (1992). A major binding protein for leukemia inhibitory factor in normal mouse serum: identification as a soluble form of the cellular receptor. Proc. Natl Acad. Sci. USA, 89, 8616-8620.
47. Li, M., Sendtner, M. & Smith, A. (1995). Essential function of LIF receptor in motor neurons. Nature, 378, 724-727.
48. Lust, J.A., Donovan, K.A., Kline, M.P., Greipp, P.R., Kyle, R.A. & Maihle, N.J. (1992). Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor. Cytokine, 4, 96-100.
49. Lust, J.A., Jelinek, D.F., Donovan, K.A., Frederick, L.A., Huntley, B.K., Braaten, J.K. & Maihle, N.J. (1995). Sequence, expression and function of an mRNA encoding a soluble form of the human interleukin-6 receptor (sIL-6R). Curr. Top. Microbiol. Immunol., 194, 199-206.
50. März, P., Cheng, J.-C., Gadient, R.A., Patterson, P., Stoyan, T., Otten, U. & Rose-John, S. (1998). Sympathetic neurons can produce and respond to Interleukin-6. Proc. Natl Acad. Sci. USA, 95, 3251-3256.
51. März, P., Gadient, R.A. & Otten, U. (1996). Expression of interleukin-6 receptor (IL-6R) and gp130 mRNA in PC12 cells and sympathetic neurons: modulation by tumor necrosis factor alpha (TNF-alpha). Brain Res., 706, 71-79.
52. März, P., Heese, K., Dimitriades-Schmutz, B., Rose-John, S. & Otten, U. (1999). Role of interleukin-6 and soluble IL-6 receptor in region specific induction of astrocytic differentiation and neurotrophin expression. Glia, 26, 191-200.
53. März, P., Heese, K., Hock, C., Golombowski, S., Müller-Spahn, F., Rose-John, S. & Otten, U. (1997a). Interleukin-6 (IL-6) and soluble forms of IL-6 receptors are not altered in cerebrospinal fluid of Alzheimer's disease patients. Neurosci. Lett., 239, 29-32.
54. März, P., Herget, T., Lang, E., Otten, U. & Rose-John, S. (1997b). Activation of gp130 by IL-6/soluble IL-6 Receptor Induces Neuronal Differentiation. Eur. J. Neurosci., 9, 2765-2773.
55. Masu, Y., Wolf, E., Holtmann, B., Sendtner, M., Brem, G. & Thoenen, H. (1993). Disruption of the CNTF gene results in motor neuron degeneration. Nature, 365, 27-32.
56. McGeer, P.L. & McGeer, E.G. (1995). The inflammatory response of the brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res. Rev., 21, 195-218.
57. Mehler, M.F. & Kessler, J.A. (1997). Hematolymphopoietic and inflammatory cytokines in neuronal development. Trends Neurosci., 20, 357-365.
58. Modur, V., Li, Y., Zimmerman, G.A., Prescott, S.M. & McIntyre, T.M. (1997). Retrograde inflammatory signaling from neutrophils to endothelial cells by soluble interleukin-6 receptor alpha. J. Clin. Invest, 100, 2752-2756.
59. Moreau, J.F., Donaldson, D.D., Bennett, F., Witek Giannotti, J., Clark, S.C. & Wong, G.G. (1988). Leukaemia inhibitory factor is identical to the myeloid growth factor human interleukin for DA cells. Nature, 336, 690-692.
60. Mosley, B., De Imus, C., Friend, D., Boiani, N., Thoma, B., Park, L.S. & Cosman, D. (1996). Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation. J. Biol. Chem., 271, 32635-32643.
61. Müllberg, J., Schooltink, H., Stoyan, T., Gunther, M., Graeve, L., Buse, G., Mackiewicz, A., Heinrich, P.C. & Rose-John, S. (1993). The soluble interleukin-6 receptor is generated by shedding. Eur. J. Immunol., 23, 473-480.
62. Müller-Newen, G., Küster, A., Hemmann, U., Keul, R., Horsten, U., Martens, A., Graeve, L., Wijdenes, J. & Heinrich, P.C. (1998). Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses. J. Immunol., 161, 6347-6355.
63. Nandurkar, H.H., Robb, L., Tarlinton, D., Barnett, L., Kontgen, F. & Begley, C.G. (1997). Adult mice with targeted mutation of the interleukin-11 receptor (IL11Ra) display normal hematopoiesis. Blood, 90, 2148-2159.
64. Narazaki, M., Yasukawa, K., Saito, T., Ohsugi, Y., Fukui, H., Koishihara, Y., Yancopoulos, G.D., Taga, T. & Kishimoto, T. (1993). Soluble forms of the interleukin-6 signal-transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130. Blood, 82, 1120-1126.
65. Novick, D., Cohen, B. & Rubinstein, M. (1992). Soluble interferon-alpha receptor molecules are present in body fluids. FEBS Lett., 314, 445-448.
66. Novick, D., Engelmann, H., Wallach, D. & Rubinstein, M. (1989). Soluble cytokine receptors are present in normal human urine. J. Exp. Med., 170, 1409-1414.
67. Oh, J.-W., van Wagoner, N., Rose-John, S. & Benveniste, E.N. (1998). Role of IL-6 and the Soluble IL-6 Receptor in Inhibition of VCAM-1 Gene Expression. J. Immunol., 161, 4992-4999.
68. Pennica, D., Arce, V., Swanson, T.A., Vejsada, R., Pollock, R.A., Armanini, M., Dudley, K., Phillips, H.S., Rosenthal, A., Kato, A.C. & Henderson, C.E. (1996a). Cardiotrophin-1, a cytokine present in embryonic muscle, supports long-term survival of spinal motoneurons. Neuron, 17, 63-74.
69. Pennica, D., Wood, W.I. & Chien, K.R. (1996b). Cardiotrophin-1: a multifunctional cytokine that signals via LIF receptor-gp 130 dependent pathways. Cytokine Growth Factor Rev., 7, 81-91.
70. Peters, M., Odenthal, M., Schirmacher, P., Blessing, M., Ciliberto, G., Meyer zum Büschenfelde, K.H. & Rose-John, S. (1997a). Soluble IL-6 Receptor leads to a paracrine modulation of the hepatic acute phase response in double transgenic mice. J. Immunol., 159, 1474-1481.
71. Peters, M., Schirmacher, P., Goldschmitt, J., Odenthal, M., Peschel, C., Dienes, H.P., Fattori, E., Ciliberto, G., Meyer zum Büschenfelde, K.H. & Rose-John, S. (1997b). Extramedullary expansion of hematopoietic progenitor cells in IL-6/sIL-6R double transgenic mice. J. Exp. Med., 185, 755-766.
72. Ringheim, G.E., Szczepanik, A.M., Petko, W., Burgher, K.L., Zhu, S.Z. & Chao, C.C. (1998). Enhancement of beta-amyloid precursor protein transcription and expression by the soluble interleukin-6 receptor/ interleukin-6 complex. Brain Res. Mol. Brain Res., 55, 35-44.
73. Romano, M., Sironi, M., Toniatti, C., Polentarutti, N., Fruscella, P., Ghezzi, P., Faggioni, R., Luini, W., van Hinsbergh, V., Sozzani, S., Bussolino, F., Poli, V., Ciliberto, G. & Mantovani, A. (1997). Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity, 6, 315-325.
74. Rose-John, S. & Heinrich, P.C. (1994). Soluble receptors for cytokines and growth factors: generation and biological function. Biochem. J., 300, 281-290.
75. Rose-John, S., Schooltink, H., Lenz, D., Hipp, E., Dufhues, G., Schmitz, H., Schiel, X., Hirano, T., Kishimoto, T. & Heinrich, P.C. (1990). Studies on the structure and regulation of the human hepatic interleukin-6 receptor. Eur. J. Biochem., 190, 79-83.
76. Rothwell, N.J. & Hopkins, S.J. (1995). Cytokines and the nervous system II: actions and mechansims of action. Trends Neurosci., 18, 130-136.
77. Satoh, T., Nakamura, S., Taga, T., Matsuda, T., Hirano, T., Kishimoto, T. & Kaziro, Y. (1988). Induction of neuronal differentiation in PCo12: cells by B-cell stimulatory factor 2/interleukin 6. Mol. Cell Biol., 8, 3546-3549.
78. Sawada, M., Itoh, Y., Suzumura, A. & Marunouchi, T. (1993). Expression of cytokine receptors in cultured neuronal and glial cells. Neurosci. Lett., 160, 131-134.
79. Schäfer, K.H., Mestres, P., März, P. & Rose-John, S. (1999). The IL-6/sIL-6R fusion protein promotes neurite outgrowth and neuronal survival in cultured enteric neurons. J. Interferon Cytokine Res., 19, 527-532.
80. Schobitz, B., Holsboer, F., Kikkert, R., Sutanto, W. & De Kloet, E.R. (1992). Peripheral and central regulation of IL-6 gene expression in endotoxin-treated rats. Endocr. Regul., 26, 103-109.
81. Sendtner, M., Carroll, P., Holtmann, B., Hughes, R.A. & Thoenen, H. (1994a). Ciliary neurotrophic factor. J. Neurobiol., 25, 1436-1453.
82. Sendtner, M., Dittrich, F., Hughes, R.A. & Thoenen, H. (1994b). Actions of CNTF and neurotrophins on degenerating motoneurons: preclinical studies and clinical implications. J. Neurol. Sci., 124 (Suppl.), 77-83.
83. Sendtner, M., Gotz, R., Holtmann, B., Escary, J.L., Masu, Y., Carroll, P., Wolf, E., Brem, G., Brulet, P. & Thoenen, H. (1996). Cryptic physiological trophic support of motoneurons by LIF revealed by double gene targeting of CNTF and LIF. Curr. Biol., 6, 686-694.
84. Sendtner, M., Götz, R., Holtmann, B. & Thoenen, H. (1997). Endogenous ciliary neurotrophic factor is a lesion factor for axotomized motoneurons in adult mice. J. Neurosci., 17, 6999-7006.
85. Sendtner, M., Stöckli, K.A. & Thoenen, H. (1992). Synthesis and localization of ciliary neurotrophic factor in the sciatic nerve of the adult rat after lesion and during regeneration. J. Cell Biol., 118, 139-148.
86. Sprang, S.R. & Bazan, J.F. (1993). Cytokine structural taxonomy and mechanism of receptor engagement. Curr. Opin. Struct. Biol., 3, 815-827.
87. Stoyan, T., Michaelis, U., Schooltink, H., Van Dam, M., Rudolph, R., Heinrich, P.C. & Rose-John, S. (1993). Recombinant soluble human interleukin-6 receptor. Expression in Escherichia coli, renaturation and purification. Eur. J. Biochem., 216, 239-245.
88. Sui, X., Tsuji, K., Tanaka, R., Tajima, S., Muraoka, K., Ebihara, Y., Ikebuchi, K., Yasukawa, K., Taga, T., Kishimoto, T. & Nakahata, T. (1995). gp130 and c-Kit signalings synergize for ex vivo expansion of human primitive hemopoietic progenitor cells. Proc. Natl Acad. Sci. USA, 92, 2859-2863.
89. Taga, T., Hibi, M., Hirata, Y., Yamasaki, K., Yasukawa, K., Matsuda, T., Hirano, T. & Kishimoto, T. (1989). Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell, 58, 573-581.
90. Taga, T. & Kishimoto, T. (1997). gp130 and the interleukin-6 family of cytokines. Annu. Rev. Immunol., 15, 797-819.
91. Thier, M., Hall, M., Heath, J.K., Pennica, D. & Weis, J. (1999a). Trophic effects of cardiotrophin-1 and interleukin-11 on rat dorsal root ganglion neurons in vitro. Brain Res. Mol Brain Res., 64, 80-84.
92. Thier, M., März, P., Otten, U., Weis, J. & Rose-John, S. (1999b). Interleukin-6 (IL-6) supports survival of sensory neurons: autocrine trophic effects of IL-6 and soluble IL-6 receptor and enhanced activity of an IL-6 designer cytokine. J. Neurosci. Res., 55, 411-422.
93. Toniatti, C., Cabibbo, A., Sporena, E., Salvati, A.L., Cerretani, M., Serafini, S., Lahm, A., Cortese, R. & Ciliberto, G. (1996). Engineering human interleukin-6 to obtain variants with strongly enhanced bioactivity. EMBO J., 15, 2726-2737.
94. Vallieres, L. & Rivest, S. (1997). Regulation of the genes encoding Interleukin-6, its receptor, and gp130 in the rat brain in response to the immune activator lipopolysaccharide and the proinflammatory cytokine interleukin-1beta. J. Neurochem., 69, 1668-1683.
95. Ware, C.B., Horowitz, M.C., Renshaw, B.R., Hunt, J.S., Liggitt, D., Koblar, S.A., Gliniak, B.C., McKenna, H.J., Papayannopoulou, T., Thoma, B., Cheng, L., Donovan, P.J., Peschon, J.J., Bartlett, P.F., Willis, C.R., Wright, B.D., Carpenter, M.K., Davison, B.L. & Gearing, D.P. (1995). Targeted disruption of the low-affinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death. Development, 121, 1283-1299.
96. Weis, J., Lie, D.C., Ragoss, U., Zuchner, S.L., Schroder, J.M., Karpati, G., Farruggella, T., Stahl, N., Yancopoulos, G.D. & DiStefano, P.S. (1998). Increased expression of CNTF receptor alpha in denervated human skeletal muscle. J. Neuropathol. Exp. Neurol., 57, 850-857.
97. Wells, J.A. (1996). Binding in the growth hormone receptor complex. Proc. Natl Acad. Sci. USA, 93, 1-6.
98. Wood, J.A., Wood, P.L., Ryan, R., Graff Radford, N.R., Pilapil, C., Robitaille, Y. & Quirion, R. (1993). Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1 beta or IL-1RA but increases in the associated acute phase proteins IL-6, alpha 2-macroglobulin and C-reactive protein. Brain Res., 629, 245-252.
99. Wu, Y.Y. & Bradshaw, R.A. (1996). Induction of neurite outgrowth by interleukin-6 is accompanied by activation of Stat3 signaling pathway in a variant PC12 cell (E2) line. J. Biol. Chem., 271, 13023-13032.
100. Yamamori, T., Fukada, K., Aebersold, R., Korsching, S., Fann, M.J. & Patterson, P.H. (1989). The cholinergic neuronal differentiation factor from heart cells is identical to leukemia inhibitory factor [published erratum appears in Science 1990 Jan 19; 247 (4940), 271]. Science, 246, 1412-1416.
101. Yamasaki, K., Taga, T., Hirata, Y., Yawata, H., Kawanishi, Y., Seed, B., Taniguchi, T., Hirano, T. & Kishimoto, T. (1988). Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor. Science, 241, 825-828.
102. Yan, H.Q., Banos, M.A., Herregodts, P., Hooghe, R. & Hooghe Peters, E.L. (1992). Expression of interleukin (IL) -1 beta, IL-6 and their respective receptors in the normal rat brain and after injury. Eur J. Immunol., 22, 2963-2971.
103. Yao, G.L., Kato, H., Khalil, M., Kiryu, S. & Kiyama, H. (1997). Selective upregulation of cytokine receptor subchain and their intracellular signalling molecules after peripheral nerve injury. Eur J. Neurosci, 9, 1047-1054.
104. Yoshida, K., Taga, T., Saito, M., Suematsu, S., Kumanogoh, A., Tanaka, T., Fujiwara, H., Hirata, M., Yamagami, T., Nakahata, T., Hirabayashi, T., Yoneda, Y., Tanaka, K., Wang, W.Z., Mori, C., Shiota, K., Yoshida, N. & Kishimoto, T. (1996). Targeted disruption of gp130, a common signal transducer for the interleukin 6 family of cytokines, leads to myocardial and hematological disorders. Proc. Natl Acad. Sci. USA, 93, 407-411.
105. Zhang, J.G., Zhang, Y., Owczarek, C.M., Ward, L.D., Moritz, R.L., Simpson, R.J., Yasukawa, K. & Nicola, N.A. (1998). Identification and characterization of two distinct truncated forms of gp130 and a soluble form of leukemia inhibitory factor receptor alpha-chain in normal human urine and plasma. J. Biol. Chem., 273, 10798-10805.
106. Zohlnhöfer, D., Graeve, L., Rose-John, S., Schooltink, H., Dittrich, E. & Heinrich, P.C. (1992). The hepatic interleukin-6 receptor. Down-regulation of the interleukin-6 binding subunit (gp80) by its ligand. FEBS Lett., 306, 219-222.